Home > Publications database > Colonoscopy and Subsequent Risk of Parkinson’s Disease > print

001     1032081
005     20250203133215.0
024 7 _ |a 10.3233/JPD-240017
|2 doi
024 7 _ |a 1877-7171
|2 ISSN
024 7 _ |a 1877-718X
|2 ISSN
024 7 _ |a 10.34734/FZJ-2024-05984
|2 datacite_doi
024 7 _ |a 38669559
|2 pmid
024 7 _ |a WOS:001255361500011
|2 WOS
037 _ _ |a FZJ-2024-05984
082 _ _ |a 610
100 1 _ |a Holtz, Anna-Victoria
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Colonoscopy and Subsequent Risk of Parkinson’s Disease
260 _ _ |a Amsterdam
|c 2024
|b IOS Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1730118150_19542
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Background: Parkinson’s disease (PD) is caused by the misfolding and aggregation of α-synuclein in neurons into toxic oligomers and fibrils that have prion-like properties allowing them to infect healthy neurons and to be transmitted to animal models of PD by injection or oral exposure. Given α-synuclein fibrils’ potential transmission on the gut-brain axis, α-synuclein may be transmitted through colonoscopy procedures.Objective: This study examines a possible association between colonoscopy and PD.Methods: Longitudinal health insurance data of 250,000 individuals aged 50+ from 2004–2019 was analyzed. Cox proportional hazard and competing risk models with death as a competing event were estimated to calculate the risk of PD. Colonoscopy was categorized as never receiving colonoscopy, colorectal cancer (CRC) screening without or with biopsy, destruction or excision (BDE), and diagnostic colonoscopy without or with BDE.Results:We identified 6,422 new cases of PD among 221,582 individuals. The Cox model revealed a significantly increased risk of PD for patients who ever had a diagnostic colonoscopy without or with BDE (HR = 1.31; 95% CI: [1.23–1.40]; HR= 1.32 [1.22–1.42]) after adjustment for age and sex. After controlling for covariates and death, persons who ever underwentCRCscreening had a 40% reduced risk ofPD(CRHR = 0.60 [0.54–0.67]), while persons who underwent diagnostic colonoscopy had a 20% reduced risk of PD (CRHR = 0.81 [0.75–0.88]).Conclusions: Colonoscopy does not increase the risk of PD, after adjusting for death and covariates. Individuals who underwent only CRC screening had the lowest risk of PD, which may be a result of a more health-conscious lifestyle.
536 _ _ |a 5244 - Information Processing in Neuronal Networks (POF4-524)
|0 G:(DE-HGF)POF4-5244
|c POF4-524
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Fink, Anne
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Tamgüney, Gültekin
|0 P:(DE-Juel1)177986
|b 2
|u fzj
700 1 _ |a Doblhammer, Gabriele
|0 P:(DE-HGF)0
|b 3
773 _ _ |a 10.3233/JPD-240017
|g Vol. 14, no. 4, p. 747 - 760
|0 PERI:(DE-600)2599550-9
|n 4
|p 747 - 760
|t Journal of Parkinson's Disease
|v 14
|y 2024
|x 1877-7171
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/1032081/files/jpd_2024_14-4_jpd-14-4-jpd240017_jpd-14-jpd240017.pdf
856 4 _ |y OpenAccess
|x icon
|u https://juser.fz-juelich.de/record/1032081/files/jpd_2024_14-4_jpd-14-4-jpd240017_jpd-14-jpd240017.gif?subformat=icon
856 4 _ |y OpenAccess
|x icon-1440
|u https://juser.fz-juelich.de/record/1032081/files/jpd_2024_14-4_jpd-14-4-jpd240017_jpd-14-jpd240017.jpg?subformat=icon-1440
856 4 _ |y OpenAccess
|x icon-180
|u https://juser.fz-juelich.de/record/1032081/files/jpd_2024_14-4_jpd-14-4-jpd240017_jpd-14-jpd240017.jpg?subformat=icon-180
856 4 _ |y OpenAccess
|x icon-640
|u https://juser.fz-juelich.de/record/1032081/files/jpd_2024_14-4_jpd-14-4-jpd240017_jpd-14-jpd240017.jpg?subformat=icon-640
909 C O |o oai:juser.fz-juelich.de:1032081
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)177986
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-524
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Molecular and Cellular Information Processing
|9 G:(DE-HGF)POF4-5244
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-24
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0
|0 LIC:(DE-HGF)CCBYNC4
|2 HGFVOC
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-24
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-08-24
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-08-24
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J PARKINSON DIS : 2022
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-10-23T11:51:45Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-10-23T11:51:45Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review, Double anonymous peer review
|d 2024-10-23T11:51:45Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-27
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-27
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J PARKINSON DIS : 2022
|d 2024-12-27
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)IBI-7-20200312
|k IBI-7
|l Strukturbiochemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)IBI-7-20200312
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21